The effectiveness of Coronavirus disease 2019 (COVID-19) vaccines against the long-term
COVID-19 symptoms expressed by a substantial proportion of patients is not well understood…

Background We determined circulating anti-S severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) immunoglobulin G (IgG) antibody titers in a vaccinated healthcare …

Objectives SARS-CoV-2 remains a global health concern 3 years after its emergence. Safe
and effective vaccines mitigate the pandemic impact, but the optimal schedule remains …

Background We determined circulating anti-S SARS-CoV-2 IgG antibody titres in a vaccinated
healthcare workers (HCWs) cohort from Northern Israel in the 11 months following primary …

(1) Background: The mechanism responsible for stroke in patients younger than 50 often
remains unknown. This study was designed to assess whether high-resolution intracranial …

Plasma collected from previously infected people to passively transfer antibodies to protect
or treat humans (convalescent plasma), has been successfully used since the late 19th …

(1) Background: Multiple acute concomitant cerebral infarcts (MACCI) are relatively uncommon.
Data regarding the characteristics and outcomes of patients with MACCI are lacking. We, …

There are different diagnostic modalities to investigate atherosclerosis cervical artery disease
in suspected stroke patients. We aimed to test the concordance of findings of the two most …

Retrospective study. The purpose of this study was to investigate the clinical symptomatology
of discopathies before and 7 days after treatment with one of the following: intravenous …

We determined whether COVID-19 vaccination was associated with Quality of Life (QoL)
changes among individuals previously infected with SARS-CoV-2 in Israel. Using a validated …